EFFICACY AND SAFETY OF RIFAXIMIN FOR PATIENTS WITH CHRONIC INTESTINAL PSEUDO-OBSTRUCTION: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 2A TRIAL
Takaomi Kessoku 1
Hidenori Ohkubo 1
TOMOKI OGATA 1
Tsumugi Jono 1
Kosuke Tanaka 1
Kota Takahashi 1
Atsushi Yamamoto 1
Tomohiro Takatsu 1
Tsutomu Yoshihara 1
Noboru Misawa 1
Keiichi Ashikari 1
Akiko Fuyuki 1
Takuma Higurashi 1
Toshihiro Misumi 2
Satoru Shinoda 2
Yukako Horikoshi 3
Emi Misugi 3
Hiroe Asuke 4
Katsuhiko Miyazawa 4
Ikuya Sato 4
Atsushi Nakajima 4
1 Yokohama City University Graduate School of Medicine, Yokohama, Japan
2 Yokohama City University School of Medicine, Yokohama, Japan
3 Yokohama City University Hospital, Yokohama, Japan
4 ASKA Pharmaceutical Co., Ltd., Tokyo, Japan
Session
Small intestinal (Posters)
Conference
UEG Week Vienna 2022
Citation
United European Gastroenterology Journal 2022; 10 (Supplement 8)
Login to access library content
Do you need help setting up your myUEG account?
Contact us at [email protected]